Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases
Antioxidants · 25.03.2023 · 12 (4) · 800
DOI: 10.3390/antiox12040800 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 25.03.2023. Verfasst von José Santiago Ibáñez-Cabellos und 3 weiteren Autor:innen. Beteiligte Einrichtung: EpiDisease S.L., Scientific Park, University of Valencia, 46026 Paterna, Spain. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIBERER Cooperative and complementary intramural actions (ACCI), Instituto de Salud Carlos III (ISCIII)-Subdirección General de Evaluación y Fomento de la Investigación, FEDER funds.
Abstract (Originalsprache)
Autoimmune diseases (ADs) such as Sjögren’s syndrome, Kawasaki disease, and systemic sclerosis are characterized by chronic inflammation, oxidative stress, and autoantibodies, which cause joint tissue damage, vascular injury, fibrosis, and debilitation. Epigenetics participate in immune cell proliferation and differentiation, which regulates the development and function of the immune system, and ultimately interacts with other tissues. Indeed, overlapping of certain clinical features between ADs indicate that numerous immunologic-related mechanisms may directly participate in the onset and progression of these diseases. Despite the increasing number of studies that have attempted to elucidate the relationship between miRNAs and oxidative stress, autoimmune disorders and oxidative stress, and inflammation and miRNAs, an overall picture of the complex regulation of these three actors in the pathogenesis of ADs has yet to be formed. This review aims to shed light from a critical perspective on the key AD-related mechanisms by explaining the intricate regulatory ROS/miRNA/inflammation axis and the phenotypic features of these rare autoimmune diseases. The inflamma-miRs miR-155 and miR-146, and the redox-sensitive miR miR-223 have relevant roles in the inflammatory response and antioxidant system regulation of these diseases. ADs are characterized by clinical heterogeneity, which impedes early diagnosis and effective personalized treatment. Redox-sensitive miRNAs and inflamma-miRs can help improve personalized medicine in these complex and heterogeneous diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- EpiDisease S.L., Scientific Park, University of Valencia, 46026 Paterna, Spain.
- U733, Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), 28029 Madrid, Spain.
- Mixed Unit for Rare Diseases INCLIVA-CIPF, INCLIVA Health Research Institute, 46010 Valencia, Spain.
- Department Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain.
- Hospital Dr. Peset, Fundación para la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO, 46010 Valencia, Spain.
ORCID-Profile: Federico V Pallardó, José Luis García-Giménez, Marta Seco-Cervera
Förderung
- CIBERER Cooperative and complementary intramural actions (ACCI)
- Instituto de Salud Carlos III (ISCIII)-Subdirección General de Evaluación y Fomento de la Investigación
- FEDER funds
- CONSELLERÍA DE INNOVACIÓN
Zitieren
APA
Ibáñez-Cabellos, J. S., Pallardó, F. V., García-Giménez, J. L., & Seco-Cervera, M. (2023). Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases. Antioxidants, 12(4), 800. https://doi.org/10.3390/antiox12040800
Vancouver
Ibáñez-Cabellos JS, Pallardó FV, García-Giménez JL, Seco-Cervera M. Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases. Antioxidants. 2023;12(4):800. doi:10.3390/antiox12040800
BibTeX
@article{IbezCabellos2023,
author = {Ibáñez-Cabellos, José Santiago and Pallardó, Federico V and García-Giménez, José Luis and Seco-Cervera, Marta},
title = {Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {4},
pages = {800},
doi = {10.3390/antiox12040800}
}
EUVIMED